Clinical Trial Update: Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating single-modality collagenase treatment versus combination with needle aponeurotomy for Dupuytren Contracture has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Contracture

Drugs mentioned

• XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

Sponsor: University of Alberta | Conditions: Dupuytren Contracture | Phase 3 | Status: WITHDRAWN